News

AM Best Elevates Assicurazioni Generali S.p.A. Ratings to Superior Status

AM Best Elevates Assicurazioni Generali S.p.A. Ratings to Superior Status

AM Best Upgrades Credit Ratings for Assicurazioni Generali S.p.A.

In recent news, AM Best has made a significant upgrade to the credit ratings of Assicurazioni Generali S.p.A. (Generali), raising its Financial Strength Rating (FSR) to A+ (Superior) from A (Excellent). Additionally, the Long-Term Issuer Credit Ratings (ICR) have also been elevated to ‘aa-’ (Superior) from ‘a+’ (Excellent). This upgrade not only applies to Assicurazioni Generali but also extends to its principal subsidiaries, demonstrating a strong alignment in the group’s overall financial health. The outlook associated with these ratings remains stable.

Insights Into Generali’s Financial Strength

The recent upgrades from AM Best are indicative of the notable improvement in Generali’s balance sheet strength fundamentals. AM Best assesses Generali’s financial position as very robust, bolstered by its solid operating performance and its ability to manage enterprise risk effectively. The evaluation considered the company’s risk-adjusted capitalisation, which, according to Best’s Capital Adequacy Ratio (BCAR), maintained the strongest level at the close of the previous financial year.

Capital and Regulatory Solvency

As of the latest reports, the group reported a Solvency II SCR ratio of 209% while showing resilience in 2024 with a previous year-end figure of 220%. One of the vital factors influencing this rating is the company’s proactive reduction in exposure to Italian sovereign bonds over the years. This strategic maneuver has led to a lessened sensitivity to the fluctuations and spreads associated with Italian government bonds. To illustrate, the importance of these bonds on Generali's balance sheet diminished significantly, dropping from EUR 63 billion in 2019 to EUR 39 billion in 2023.

Operational Performance Highlights

Generali's robust financial ratings are complemented by its strong operational performance. The company’s technical operations showcased remarkable results; in 2023, the non-life business achieved a discounted combined ratio of 94.0%. The life insurance segment remained resilient, with strong technical margins reported at 5.78% by year-end 2023, compared to 5.69% the previous year. Even though net outflows in the life business hit EUR 1.3 billion in 2023 due to rising interest rates, the company’s diversified offerings in separate account business and life protection saw significant inflows. By the end of the third quarter of 2024, management reported net inflows in life business totaling EUR 6.8 billion, demonstrating recovery and strategic agility.

Generali’s Business Profile

The favorable business profile of Generali is largely attributed to its leading market positions and a defensible franchise within core markets. The company enjoys robust market access through a proprietary network supplemented by a multichannel distribution strategy. Recently, Generali has further solidified its market presence with significant acquisitions, including the notable acquisition of Liberty Seguros, which took place earlier this year, further enhancing its competitive edge.

Subsidiary Rating Upgrades

In line with the parent company’s upgrades, the following subsidiaries have also received an upgraded Financial Strength Rating to A+ (Superior) and Long-Term ICR to ‘aa-’ (Superior) for their strong operational profiles:

  • Generali Italia S.p.A.
  • Generali Deutschland AG
  • Generali Vie S.A.
  • Generali IARD S.A.
  • Generali ?eská pojišt’ovna a.s.
  • Generali España, Sociedad Anonima de Seguros y Reaseguros
  • Generali Deutschland Versicherung AG
  • Generali Deutschland Lebensversicherung AG
  • Europ Assistance S.A.

Moreover, the Long-Term ICR of Generali France has improved to ‘a’ (Excellent) from ‘a-’ (Excellent), with a stable outlook.

Long-Term Issue Ratings Upgraded

The company’s Long-Term IRs have experienced positive upgrades, as seen with the following ratings:

For Assicurazioni Generali S.p.A.—

  • Upgraded to ‘a’ (Excellent) from ‘a-’ on EUR 1,250 million 5.5% fixed/floating rate subordinated notes due 2047 (callable in 2027)
  • Upgraded to ‘a’ (Excellent) from ‘a-’ on EUR 850 million 5% fixed/floating rate subordinated notes due 2048 (callable in 2028)
  • Upgraded to ‘a’ (Excellent) from ‘a-’ on EUR 1,000 million 4.125% fixed rate subordinated notes due 2026
  • Upgraded to ‘a’ (Excellent) from ‘a-’ for EUR 500 million 3.875% fixed rate subordinated notes due 2029
  • Upgraded to ‘a’ (Excellent) from ‘a-’ for EUR 750 million 2.124% fixed rate subordinated notes due 2030
  • Upgraded to ‘a-’ (Excellent) from ‘bbb+’ (Good) on GBP 350 million 6.269% fixed/floating rate junior perpetual debentures (callable in 2026)
  • Upgraded to ‘a-’ (Excellent) from ‘bbb+’ (Good) on EUR 1,500 million 4.596% fixed/floating rate more deeply subordinated perpetual notes originally issued by Generali Finance B.V.

Additionally, indicative Long-Term IRs available under the EUR 15 billion medium-term note program have been upgraded with stable outlooks, reflecting improving investor confidence.

Conclusion

The upgrades from AM Best are not merely reflective of improved financial metrics but underscore an ongoing commitment by Assicurazioni Generali S.p.A. to enhancing value through strategic initiatives and sound financial practices. This uplifting narrative is anchored in a solid operational backbone and proactive risk management, paving the way for a promising outlook within the insurance sector.

Frequently Asked Questions

What ratings did AM Best upgrade for Generali?

AM Best upgraded Generali's Financial Strength Rating from A to A+ and the Long-Term Issuer Credit Ratings from A+ to aa-.

What factors influenced the rating upgrades?

The upgrades were influenced by Generali's strong balance sheet strength and solid operating performance, particularly in technical results and capitalisation.

How has Generali managed its sovereign bond exposure?

Generali reduced its exposure to Italian sovereign bonds significantly, decreasing from EUR 63 billion in 2019 to EUR 39 billion in 2023.

What are Generali's recent operational results?

In 2023, Generali achieved a combined ratio of 94.0% in its non-life business and reported strong technical margins in its life segment.

Are there further acquisitions planned by Generali?

Yes, Generali has been actively increasing its market presence through strategic acquisitions, such as Liberty Seguros in 2023.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Cultural Bridges and Mazu's Spirit: Gen Z's Role

Updated Category News Views 183

Youthful Energy Revives Ancient Traditions Over in Putian, China, you'd have seen a curious sight in late October—hundreds of young folks from over 20 corners of the globe gathering not for a concert or some influencer meet-up, but to dive into Mazu's legacy. This ain't your typical cultural event. More than 200 Gen Z representatives came together, bridging their...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 156

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 74

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 103

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 88

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 168

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 166

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Klarna Group plc Investors Take Legal Action Amid Class Action Suit

Updated Category News Views 146

Klarna Group plc Investors Pursue Class Action Amid Concerns The renowned law firm Berger Montague PC is investigating claims on behalf of investors connected to Klarna Group plc (NYSE: KLAR), following a recent class action lawsuit. The firm is focused on representing individuals who purchased Klarna securities during the recent class action period. Understanding the...

Continue Reading
Saba Capital Income Fund Shares Distribution Insights

Updated Category News Views 312

Saba Capital Income Fund Announces Shareholder Distribution Sources Saba Capital Income & Opportunities Fund (NYSE: BRW), a registered closed-end management investment company on the New York Stock Exchange, is reaching out to its shareholders and interested parties with key details regarding its distribution sources under Section 19(a) of the Investment Company Act. This...

Continue Reading
Insta360 Partners with SMX Championship for Immersive Action.

Updated Category News Views 274

Insta360 Unveils Unique Partnership with SMX World Championship Insta360, a leader in innovative 360-degree action camera technology, is thrilled to announce its collaboration with the SMX League as the official action camera sponsor for the SMX World Championship. This exciting partnership enhances how fans experience the electrifying world of dirt bike racing, beginning...

Continue Reading
Revolutionizing 1031 Exchanges: The New Online Marketplace

Updated Category News Views 163

Introducing a Game-Changer for 1031 Exchanges 1031 Specialist is excited to announce the upcoming launch of its innovative online marketplace designed specifically for 1031 exchanges. This platform aims to revolutionize how investors find and evaluate replacement properties across the nation. Understanding the urgency and complexities involved in 1031 exchanges, the...

Continue Reading
Enteral Feeding Formulas Market Growth Forecast to 2032

Updated Category News Views 149

Insights into the Enteral Feeding Formulas Market The enteral feeding formulas market has shown remarkable growth, with its size reaching USD 7 billion in 2023. This segment is projected to experience a substantial compound annual growth rate (CAGR) of 7.1% from 2024 to 2032. Enteral feeding formulas are specialized liquid nutrition products aimed at individuals unable to...

Continue Reading